Shawn mcCormick - 08 May 2026 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Reporting relationship: Director
Issuer ticker: INSP
Reported as of: 08 May 2026
Net transaction value: -$31,536
SEC form: 4
Accepted by SEC: 11 May 2026, 16:05:10 UTC
Prior SEC filing: 04 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Bryan Phillips, Attorney-in-Fact for Shawn T McCormick

Key filing fact

Shawn mcCormick filed Form 4 for Inspire Medical Systems, Inc. (INSP) on 11 May 2026.

Key facts

This page summarizes Shawn mcCormick's Form 4 filing for Inspire Medical Systems, Inc. (INSP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 May 2026, 16:05.

Change

Previous filing in this sequence was filed on 04 May 2026.
Current net transaction value: -$31,536.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001454092 Primary reporting owner

mcCormick Shawn

Relationship: Director
Address: C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY
Signature: /s/ Bryan Phillips, Attorney-in-Fact for Shawn T McCormick
Signature date: 11 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSP transaction

Common Stock

Sale

Transaction value: $31,536
Shares: -696
Change %: -2.5%
Price: $45.31
Shares after: 27,712
Date: 08 May 2026
Ownership: Direct

INSP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,000
Date: 08 May 2026
Ownership: By trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

SEC remarks

All sale transactions reported herein were made pursuant to a Rule 10b5-1 trading plan dated August 29, 2025.